Illumina’s NextSeq 550Dx platform and associated reagent kits received medical device registration in Russia Kumar Jeetendra | March 13, 2021 San Diego-based Illumina’s NextSeq 550Dx platform and associated reagent kits received medical device registration in Russia, as have reagents for the MiSeqDx which was approved previously as a medical device. Both of these in vitro diagnostic (IVD)-ready solutions are available to customers and third-party developers to create diagnostic solutions using the technology. These registrations will …
